ACHE and hereditary elliptocytosis: This is not in line with our results showing a higher specificity with calretinin compared to AChE in the total group of pathologists (98.1% with calretinin versus 96.2% with AChE + HE), experienced pathologists (95.2% with calretinin versus 69.2% with AChE + HE), and unexperienced pathologists (100% with calretinin versus 65.2% with AChE + HE).